Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taha Merghoub

Showing results (161-170 of 216) with videos related to

Pageof 22
Sort By:
Nature Communications|April 12, 2022
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinomaJeppe Sejerø Holm, Samuel A Funt, Annie Borch, et al.
Science (New York, N.Y.)|March 14, 2015
Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancerNaiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
TAD hierarchy restricts poised LTR activation and loss of TAD hierarchy promotes LTR co-option in cancerElissa W P Wong, Merve Sahin, Rui Yang, et al.
The Journal of Clinical Investigation|September 15, 2022
Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockadeArnab Ghosh, Judith Michels, Riccardo Mezzadra, et al.
Cancer Discovery|June 16, 2018
Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP ProteinsMaomao Zhang, Julie S Di Martino, Robert L Bowman, et al.
Oncotarget|October 21, 2017
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibitionGongda Xue, Reto Kohler, Fengyuan Tang, et al.
Science Translational Medicine|August 26, 2021
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockadeRonglai Shen, Michael A Postow, Matthew Adamow, et al.
The Journal of Experimental Medicine|June 26, 2026
Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical modelsParwiz Abrahimi, Jonathan F Khan, Alyssa Duren-Lubanski, et al.
Cancer Cell|June 16, 2023
MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinomaYu Qian, Ana Galan-Cobo, Irene Guijarro, et al.
The Journal of Experimental Medicine|May 6, 2022
Neutrophil phenotypes and functions in cancer: A consensus statementDaniela F Quail, Borko Amulic, Monowar Aziz, et al.
Pageof 22

Showing results (161-170 of 216) with videos related to

Sort By:
Pageof 22
Nature Communications|April 12, 2022
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinomaJeppe Sejerø Holm, Samuel A Funt, Annie Borch, et al.
Science (New York, N.Y.)|March 14, 2015
Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancerNaiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
TAD hierarchy restricts poised LTR activation and loss of TAD hierarchy promotes LTR co-option in cancerElissa W P Wong, Merve Sahin, Rui Yang, et al.
The Journal of Clinical Investigation|September 15, 2022
Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockadeArnab Ghosh, Judith Michels, Riccardo Mezzadra, et al.
Cancer Discovery|June 16, 2018
Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP ProteinsMaomao Zhang, Julie S Di Martino, Robert L Bowman, et al.
Oncotarget|October 21, 2017
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibitionGongda Xue, Reto Kohler, Fengyuan Tang, et al.
Science Translational Medicine|August 26, 2021
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockadeRonglai Shen, Michael A Postow, Matthew Adamow, et al.
The Journal of Experimental Medicine|June 26, 2026
Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical modelsParwiz Abrahimi, Jonathan F Khan, Alyssa Duren-Lubanski, et al.
Cancer Cell|June 16, 2023
MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinomaYu Qian, Ana Galan-Cobo, Irene Guijarro, et al.
The Journal of Experimental Medicine|May 6, 2022
Neutrophil phenotypes and functions in cancer: A consensus statementDaniela F Quail, Borko Amulic, Monowar Aziz, et al.
Pageof 22